Cullinan Oncology Inc

NASDAQ:CGEM   10:49:14 AM EDT
23.78
-0.96 (-3.88%)
Products

Cullinan Oncology Receives FDA Clearance Of Investigational New Drug Application For Cln-619, A Novel Mica/B-Targeted Antibody For The Treatment Of Solid Tumors

Published: 06/29/2021 12:26 GMT
Cullinan Oncology Inc (CGEM) - Cullinan Oncology Receives FDA Clearance of Investigational New Drug (ind) Application for Cln-619, a Novel Mica/b-targeted Antibody for the Treatment of Solid Tumors.
Cullinan Oncology Inc - Will Initiate a Fih Trial in 3q21.